Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
2.010
-0.140 (-6.51%)
Dec 26, 2025, 1:29 PM EST

Nuo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
97662463014
Upgrade
Market Cap Growth
564.84%169.36%-61.19%2071893.52%-99.98%378.33%
Upgrade
Enterprise Value
96652460014
Upgrade
Last Close Price
2.011.400.551.500.000.45
Upgrade
PE Ratio
-----1.77
Upgrade
PS Ratio
37.0448.0139.99558.56--
Upgrade
PB Ratio
-230.52127.5923.4228.610.00-27.04
Upgrade
P/TBV Ratio
-127.5923.4228.610.00-
Upgrade
EV/Sales Ratio
36.8947.6439.48536.08--
Upgrade
Debt / Equity Ratio
-0.270.320.250.15--
Upgrade
Asset Turnover
1.430.890.250.05--
Upgrade
Inventory Turnover
4.191.680.56---
Upgrade
Quick Ratio
0.930.921.753.572.100.24
Upgrade
Current Ratio
1.161.462.324.392.180.24
Upgrade
Return on Equity (ROE)
-1032.50%-299.28%-196.34%-212.57%-62.68%-
Upgrade
Return on Assets (ROA)
-87.97%-100.16%-80.41%-91.97%-6.96%-107.90%
Upgrade
Return on Capital (ROIC)
-419.49%-155.74%-103.64%-125.05%-39.17%-
Upgrade
Return on Capital Employed (ROCE)
-382.40%-402.20%-263.30%-135.70%-11.40%75.10%
Upgrade
Earnings Yield
-2.51%-3.55%-13.03%-5.06%-2996.37%-0.67%
Upgrade
FCF Yield
-1.20%-3.64%-13.05%-6.01%-3964.14%-0.40%
Upgrade
Buyback Yield / Dilution
-6.37%-7.95%-5.19%-32.03%-10.93%-15.13%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.